Stock Track | Moderna Plummets 5.08% as Trump's Appointment of Anti-Vaxxer Kennedy Jr. as Health Secretary Spooks Markets

Stock Track11-15

Moderna, Inc.'s stock suffered a 5.08% plummet on Friday, following news that President-elect Donald Trump had selected vocal vaccine skeptic Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services.

Kennedy, an environmental activist, has been a harsh critic of public-health leaders' approaches to the Covid-19 pandemic and vaccines. He has claimed that unhealthy food, medicines, and water have fueled the rise of chronic diseases in America and accused government regulators of being corrupted by corporate influence.

The appointment sparked concerns among investors, as Kennedy has vowed to overhaul the healthcare industry, particularly the vaccine sector. Shares of other vaccine makers, including Pfizer, BioNTech, and Novavax, also tumbled premarket, indicating widespread apprehension about Kennedy's potential impact on the industry's future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment